Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. 2014

Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
1] Department of Clinical Pharmacology, AP-HP, H.Mondor-A.Chenevier hospital, Créteil, France [2] Paris-Est University, Faculté de Médecine, Créteil, France [3] Neuropsychologie Interventionnelle, INSERM U955, Créteil, France.

Increased blood pressure variability (BPV) contributes to end-organ damage, cardiovascular events and mortality associated with hypertension. In a cohort of 2780 hypertensive patients treated by either calcium channel blockers (CCBs), diuretics, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs) or β-blockers alone or in combination, we compared indices of short-term BPV according to the different treatments. Short-term BPV was calculated as the standard deviation (s.d.) of 24 h, daytime or nighttime systolic blood pressure and diastolic blood pressure (SBP and DBP). Short-term BPV was compared between patients treated with a given antihypertensive class of interest (alone or in combination) and those not treated with this class, after controlling for ambulatory average blood pressure, heart rate, age, gender, propensity scores and carotid-femoral pulse wave velocity. Patients treated with CCBs (n=1247) or diuretics (n=1486) alone, or in addition to other drugs had significant lower s.d. of 24-h SBP compared with those not treated with these classes (mean differences in s.d. -0.50±0.50 mm Hg, P=0.001 and -0.17±0.15 mm Hg, P=0.05, respectively). There was no significant difference regarding treatment with or without ARBs, ACEIs and β-blockers. The combinations of CCBs with diuretics or ARBs on top of other treatments resulted in a lower 24-h SBP variability (mean differences in s.d. -0.43±0.17 mm Hg, P=0.02 and -0.44±0.19 mm Hg, P=0.005 vs. other combination uses, respectively). Antihypertensive drug classes have differential effects on short-term BPV with a greater reduction in patients treated with CCBs and diuretics. The combinations of CCBs with diuretics may be the most efficient treatments in lowering BPV.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
February 2021, Journal of hypertension,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
January 1998, Fundamental & clinical pharmacology,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
February 2010, Clinical and experimental pharmacology & physiology,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
December 1991, Clinical autonomic research : official journal of the Clinical Autonomic Research Society,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
November 2003, Clinical science (London, England : 1979),
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
January 1995, Clinical and experimental hypertension (New York, N.Y. : 1993),
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
January 2003, American journal of hypertension,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
January 1988, American journal of hypertension,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
July 2019, European journal of preventive cardiology,
Natacha Levi-Marpillat, and Isabelle Macquin-Mavier, and Anne-Isabelle Tropeano, and Gianfranco Parati, and Patrick Maison
August 1996, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!